Expression of APO2.7, bcl-2 and bax apoptosis-associated proteins in CD34- bone marrow cell compartments from patients with myelodysplastic syndromes [3]

Leukemia

Volumn 18, Issue 7, 2004, Pages 1311-1313

  Suarez L ^a,b   Vidriales, M B ^a,b   Sanz, G ^c   Lopez A ^d   Lopez Berges M C ^a   de Santiago, M ^d   Palomera, L ^e   Bernal, T ^f   Perez de Equiza M E ^g   San Miguel, J F ^a,b   Orfao, A ^b,d  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b Centro de Investigacion del Cancer   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d UNIVERSITY OF SALAMANCA   (Spain)

^e Lozano Blesa Hospital   (Spain)

^f Hospital de Asturias   (Spain)

^g Universidad Pública de Navarra   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MEMBRANE PROTEIN; PROTEIN APO2.7; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; BAX PROTEIN, HUMAN; ONCOPROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; BONE MARROW CELL; BONE MARROW EXAMINATION; CANCER RISK; CANCER SUSCEPTIBILITY; CELL COMPARTMENTALIZATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE MARKER; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; LETTER; LEUKEMOGENESIS; MYELODYSPLASTIC SYNDROME; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; BIOSYNTHESIS; CHEMISTRY; PATHOLOGY;

ANTIGENS, CD34; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BONE MARROW CELLS; FLOW CYTOMETRY; HUMANS; MYELODYSPLASTIC SYNDROMES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 3543145934     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403386     Document Type: Letter

References (8)

1. Parker JE, Mufti GJ. The role of apoptosis in the pathogenesis of the myelodysplastic syndromes. Int J Hematol 2001; 73: 416-428.
2. Koester SK, Roth P, Mikulka WR, Schlossman SF, Zhang C, Bolton WE. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. Cytometry 1997; 29: 306-312.
3. Suárez L, Vidriales B, García-Larana J, López A, Martínez R, PETHEMA Cooperative Group et al. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia. Haematologica 2001; 86: 1287-1295.
4. van de Loosdrecht AA, Brada SJ, Blom NR, Hendriks DW, Smit JW, van den Berg E et al. Mitochondrial disruption and limited apoptosis of erythroblasts are associated with high risk myelodysplasia. An ultrastructural analysis. Leukemia Res 2001; 25: 385-393.
5. Raza A, Gezer S, Mundle S, Gao X-Z, Alvis S, Borok R et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 1: 268-276.
6. Huh YO, Jilani I, Estey E, Giles F, Kantarjian H, Freireich E et al. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia. Leukemia 2002; 16: 2249-2252.
7. Carthy CM, Granville DJ, Jiang H, Levy JG, Rudin CM, Thompson CB et al. Early release of mitochondrial cytocrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photo-sensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity. Lab Invest 1999; 79: 953-965.
8. Tehranchi R, Fadeel B, Forsblom AM, Christensson B, Samuelsson J, Zhivotovsky B et al. Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. Blood 2003; 101: 1080-1086.